Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2018 16:30 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018

DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Wednesday, May 9, 2018 at 4:30 p.m. ET to discuss first quarter 2018 financial...
March 19, 2018 08:00 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong

DURHAM, N.C., March 19, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare...
March 08, 2018 08:00 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals to Present at Cowen 38th Annual Health Care Conference

DURHAM, N.C., March 08, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at...
February 22, 2018 19:30 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals, Inc. Announces Pricing of Offering of Common Stock

DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare...
February 20, 2018 16:05 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals, Inc. Announces Proposed Offering of Common Stock

DURHAM, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare...
February 15, 2018 16:05 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Operating and Financial Results

DURHAM, N.C., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare...
February 12, 2018 17:00 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals to Present at Leerink Partners 7th Annual Global Healthcare Conference

DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at...
February 12, 2018 16:15 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018

DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Thursday, February 15, 2018 at 4:30 p.m. EST to discuss fourth quarter and...
January 30, 2018 07:00 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer

DURHAM, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the appointment of Mark W. Hahn as the company’s Chief Financial Officer. A veteran Chief...
January 03, 2018 16:30 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at...